Page last updated: 2024-11-06

resorantel

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Resorantel is an anthelmintic drug used primarily in veterinary medicine to treat parasitic infections in animals, particularly tapeworms in ruminants. It has a broad spectrum of activity against various cestode species. The mechanism of action of resorantel involves disrupting the parasite's energy metabolism by inhibiting the enzyme succinate dehydrogenase. This enzyme plays a crucial role in the electron transport chain, which is essential for ATP production in the parasite. By inhibiting this enzyme, resorantel disrupts the parasite's energy supply, leading to its death. Resorantel is typically administered orally to animals, and it is well-absorbed from the gastrointestinal tract. It is then distributed throughout the body, reaching high concentrations in the tissues where parasites reside. Resorantel is commonly used in livestock, such as cattle, sheep, and goats, to treat tapeworm infections, which can cause significant weight loss and reduced productivity in these animals. Research on resorantel focuses on understanding its efficacy against different parasite species, optimizing its administration, and exploring potential adverse effects. It is also being investigated for its potential to treat parasitic infections in humans, though it is currently not approved for human use.'

resorantel: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65696
CHEMBL ID2105347
SCHEMBL ID1027956
MeSH IDM0041000

Synonyms (36)

Synonym
resorantel
n-(4-bromophenyl)-2,6-dihydroxybenzamide
FT-0655787
resorantelum [inn-latin]
unii-2i8v5q9a78
4'-bromo-gamma-resorcylanilide
4'-brom-2,6-dihydroxybenzanilid
resorantel [inn]
resorantelum
einecs 244-040-9
hoe 296 v
2i8v5q9a78 ,
benzamide, n-(4-bromophenyl)-2,6-dihydroxy-
20788-07-2
A814899
hoe-296-v
hoe-296 v
CHEMBL2105347
AKOS015896441
SCHEMBL1027956
resorantel [mi]
DTXSID80174879
sr-01000945074
SR-01000945074-1
AS-65720
E75929
sodiumbisulfide
CCG-267556
Q27254786
resorantel 100 microg/ml in acetonitrile
S4882
HY-121477
CS-0082168
Z1574812100
SY113738
mfcd00864511

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Treatment with resorantel at 65 mg/kg or niclosamide at 50 mg/kg however, caused expulsion of the strobilae within 16--24 hours after treatment and at autopsy, lambs were free of scoleces of T."( The efficacy of anthelmintics against Thysaniezia giardi in South Africa.
Davies, PV; Geyser, TL; RĂ©cio, M; Van Schalkwyk, PC, 1981
)
0.6

Dosage Studied

ExcerptRelevanceReference
" was tested in sheep at a dosage rate of 65 mg kg-1 live mass."( The anthelmintic efficacy of resorantel against cestodes in sheep.
Ashburner, AJ; du Plessis, CA; Gruss, B; Malan, FS; Roper, NA, 1988
)
0.57
"Resorantel at a dosage rate of 130 mg kg-1 live body mass was found to be highly effective against Houttuynia struthionis in ostriches when dosed alone or in combination with fenbendazole or levamisole."( The anthelmintic efficacy of resorantel against Houttuynia struthionis in ostriches.
Ashburner, AJ; du Plessis, C; Gruss, B; Malan, FS; Roper, NA, 1988
)
2.01
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.52 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]